Contact us today to schedule a consultation and learn how Glutathione IV therapy can benefit you.
The FDA has approved GLP-1s for individuals with a BMI (Body Mass Index) of 30 or higher or a BMI of 27 or higher with comorbidities like high blood pressure or diabetes
Mol Cell Biol 15 : 35163522 Werner H, Stannard B, Bach MA, Roberts Jr CT, LeRoith D (1991) Regulation of insulin-like growth factor I receptor gene expression in normal and pathological states
GLP-1 receptor agonists (GLP-1RAs) are well-established treatments for type 2 diabetes and obesity
Finland Research suggests that VIP may also have neuroprotective effects and be involved in pain modulation (4)
There is no strong evidence of universal depletion, but intake-related vulnerability may occur with: Iron Vitamin B12 Folate Magnesium Zinc Vitamin D Protein Risk is most closely linked to reduced food volume and reduced dietary diversity rather than direct malabsorption